Healthcare -
Biotechnology - NASDAQ - US
$ 5.75
-4.61 %
$ 123 M
Market Cap
-1.28
P/E
ENTA - REVENUE
Revenue ENTA - Enanta Pharmaceuticals, Inc.
67.6 M
LAST VALUE
-11.40%
2 YEAR CAGR
-19.91%
5 YEAR CAGR
3.54%
10 YEAR CAGR